Select Publications

Journal articles

Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G, 2013, 'Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.', The Journal of antimicrobial chemotherapy, 68, pp. 1445 - 1447, http://dx.doi.org/10.1093/jac/dkt017

Lahra MM, 2013, 'Gonococcal surveillance Australia: quarter 3, 2012.', Communicable diseases intelligence quarterly report, 37

Goire N; Lahra MM; Ohnishi M; Hogan T; Liminios AE; Nissen MD; Sloots TP; Whiley DM, 2013, 'Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain', Eurosurveillance, 18, http://dx.doi.org/10.2807/1560-7917.ES2013.18.14.20444

Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM, 2012, 'The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance', Sexual Health, 9, pp. 422 - 429, http://dx.doi.org/10.1071/SH12026

Saab J; Bell SM; Lahra MM, 2012, 'Vaginal carriage rate of streptococcal pyogenes in 1600 pregnant women', PATHOLOGY, 44, pp. 567 - 568, http://dx.doi.org/10.1097/PAT.0b013e3283582983

Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW, 2012, 'In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: Ertapenem for treatment of gonorrhea?', Antimicrobial Agents and Chemotherapy, 56, pp. 3603 - 3609, http://dx.doi.org/10.1128/AAC.00326-12

Goire N; Ohnishi M; Limnios AE; Lahra MM; Lambert SB; Nimmo GR; Nissen MD; Sloots TP; Whiley DM, 2012, 'Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: A real-time pcr assay for direct detection of the neisseria gonorrhoeae h041 strain', Journal of Antimicrobial Chemotherapy, 67, pp. 902 - 905, http://dx.doi.org/10.1093/jac/dkr549

BaAlawi F; Robertson PW; Lahra M; Rawlinson WD, 2012, 'Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection', Pathology, 44, pp. 381 - 383, http://dx.doi.org/10.1097/PAT.0b013e328353bec0

Lahra MM, 2012, 'Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010.', Communicable diseases intelligence quarterly report, 36, pp. 95 - 100

Saab J; Bell SM; Lahra MM, 2012, 'Vaginal carriage rate of streptococcal pyogenes in 1600 pregnant women', Pathology, 44, pp. 567 - 568, http://dx.doi.org/10.1097/PAT.0b013e3283582983

Whiley D; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots T, 2012, 'The ticking time bomb: escalating drug resistance in Neisseria gonorrhoeae is a public health disaster in waiting', Journal of Antimicrobial Chemotherapy, 67, pp. 2059 - 2061

Yin JK; Lahra MM; Iskander M; Lambert SB; Heron L; Nissen MD; Rost L; Murphy J; Sloots TP; Booy R, 2011, 'Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare', Journal of Paediatrics and Child Health, 47, pp. 857 - 862, http://dx.doi.org/10.1111/j.1440-1754.2011.02098.x

Gordon A; Lahra M; Raynes-Greenow C; Jeffery H, 2011, 'Histological chorioamnionitis is increased at extremes of gestation in stillbirth: A population-based study', Infectious Diseases in Obstetrics and Gynecology, 2011, http://dx.doi.org/10.1155/2011/456728

Lahra MM, 2011, 'Additional reports', COMMUNICABLE DISEASES INTELLIGENCE, 35, pp. 257 - 260, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM, 2011, 'Australian Gonococcal Surveillance Programme annual report, 2010', COMMUNICABLE DISEASES INTELLIGENCE, 35, pp. 229 - 236, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra MM, 2011, 'Meningococcal surveillance', COMMUNICABLE DISEASES INTELLIGENCE, 35, pp. 261 - 261, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213220100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra M, 2011, 'SURVEILLANCE OF ANTIBIOTICIC RESISTANCE IN NEISSERIA GONORRHOEAE IN THE WHO WESTERN PACIFIC AND SOUTH EAST ASIAN REGIONS, 2009', COMMUNICABLE DISEASES INTELLIGENCE, 35, pp. 2 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213218600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra M; Tapsall J, 2010, 'Gonococcal surveillance', COMMUNICABLE DISEASES INTELLIGENCE, 34, pp. 369 - 370, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213215700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lahra M; Tapsall J, 2010, 'ANNUAL REPORT OF THE AUSTRALIAN GONOCOCCAL SURVEILLANCE PROGRAMME, 2009', COMMUNICABLE DISEASES INTELLIGENCE, 34, pp. 89 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213215200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tapsall JW, 2010, 'Annual report of the Australian Meningococcal Surveillance Programme, 2009', , http://www.health.gov.au/internet/main/publishing.nsf/content/cda-cdi3403g.htm

Lahra MM; Beeby PJ; Jeffery HE, 2009, 'Intrauterine inflammation, neonatal sepsis, and chronic lung disease: A 13-year hospital cohort study', Pediatrics, 123, pp. 1314 - 1319, http://dx.doi.org/10.1542/peds.2008-0656

Lahra MM; Beeby PJ; Jeffery HE, 2009, 'Maternal versus fetal inflammation and respiratory distress syndrome: A 10-year hospital cohort study', Archives of Disease in Childhood: Fetal and Neonatal Edition, 94, http://dx.doi.org/10.1136/adc.2007.135889

Lahra MM, 2008, 'Intrauterine infection: preterm birth and pulmonary impact', MICROBIOLOGY AUSTRALIA, 29, pp. 217 - 219, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000216277300017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Best EJ; Lahra MM; Palasanthiran P, 2005, 'An unusual neonatal zoonosis [1]', Medical Journal of Australia, 182, pp. 137, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06619.x

Lahra MM; Robertson PW; Whybin R; Tapsall JW, 2005, 'Enhanced serological diagnosis of invasive meningococcal disease by determining anti-group C capsule IgM antibody by enzyme immunoassay', Pathology, 37, pp. 239 - 241, http://dx.doi.org/10.1080/00313020500098983

Lahra MM; Jeffery HE, 2004, 'A fetal response to chorioamnionitis is associated with early survival after preterm birth', American Journal of Obstetrics and Gynecology, 190, pp. 147 - 151, http://dx.doi.org/10.1016/j.ajog.2003.07.012

Nolan MA; Craig ME; Lahra MM; Rawlinson WD; Prager PC; Williams GD; Bye AM; Andrews PI, 2003, 'Survival after pulmonary edema due to enterovirus 71 encephalitis', Neurology, 60, pp. 1651 - 1656

Jeffery HE; Lahra MM, 1998, 'Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers', PEDIATRICS, 101, http://dx.doi.org/10.1542/peds.101.1.e2

Jeffery HE; Lahra MM, 1998, 'Neonatal Outcomes Eight Years After Universal Screening and Non-selective Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers 1451', Pediatric Research, 43, pp. 248 - 248, http://dx.doi.org/10.1203/00006450-199804001-01472

Bolton P; Mira M; Kennedy P; Lahra MM, 1998, 'The quality of communication between hospitals and general practitioners: an assessment.', J Qual Clin Pract, 18, pp. 241 - 247, http://dx.doi.org/10.1046/j.1440-1762.1998.00281.x


Back to profile page